Nan Fung Group Holdings Ltd
KAI TAK, K3 · CIK 1782539 · 13F filing filed 2026-08-13
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyHong Kong
$131.5m
reported value
+8.4% vs Q1 2026
25positions
82.4%in top 10
2 new
1 added
2 reduced
1 sold out
vs Q1 2026
This report includes the holdings of 2 other managers that share the investment decisions:
- Pivotal bioVenture Partners Investment Advisor LLC – files its own report too; $47.4m of shares are in both
- Pivotal bioVenture Partners Fund I U.G.P. Ltd – reports through this filing
Shares in two reports are counted once in each security's totals.
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| MAPLIGHT THERAPEUTICS INC MPLT | $34.8m26.47% | Unchanged |
| LB PHARMACEUTICALS INC LBRX | $20.5m15.57% | Unchanged |
| EVOMMUNE INC EVMN | $19.2m14.56% | Unchanged |
| CYBIN INC COM NEW | $6.5m4.96% | Added +527.2k |
| INCYTE CORP INCY | $6.1m4.63% | Unchanged |
| RHYTHM PHARMACEUTICALS INC RYTM | $5.5m4.15% | Unchanged |
| BEIGENE LTD ONC | $4.5m3.41% | Unchanged |
| OCULIS HOLDING AG OCS | $4.2m3.17% | Reduced -50.2k |
| ASCENDIS PHARMA A/S ASND | $3.6m2.76% | New |
| REVOLUTION MEDICINES INC RVMD | $3.6m2.74% | Unchanged |
| KYMERA THERAPEUTICS INC KYMR | $3.5m2.69% | Unchanged |
| MADRIGAL PHARMACEUTICALS INC MDGL | $3.0m2.32% | Unchanged |
| CELCUITY INC CELC | $3.0m2.25% | Unchanged |
| ACADIA PHARMACEUTICALS INC ACAD | $2.6m1.98% | Unchanged |
| ARGENX SE ARGX | $2.6m1.98% | Unchanged |
| RECURSION PHARMACEUTICALS IN RXRX | $2.2m1.66% | Unchanged |
| PROCORE TECHNOLOGIES INC PCOR | $2.2m1.65% | Unchanged |
| HARMONY BIOSCIENCES HLDGS IN HRMY | $984.9k0.75% | Unchanged |
| INSMED INC INSM | $701.6k0.53% | Unchanged |
| ISHARES ETHEREUM TR ETHA | $601.0k0.46% | Unchanged |
| ISHARES BITCOIN TRUST ETF IBIT | $531.6k0.40% | Unchanged |
| CHIME FINL INC CHYM | $431.6k0.33% | New |
| RANI THERAPEUTICS HLDGS INC RANI | $375.3k0.29% | Unchanged |
| ENTRADA THERAPEUTICS INC TRDA | $361.2k0.27% | Unchanged |
| BOLT BIOTHERAPEUTICS INC BOLT | $19.2k0.01% | Reduced -24.2k |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| ASCENDIS PHARMA A/S | $3.1m13.6k shares |